Description
dUpNHpp, a formidable small molecule inhibitor with potential therapeutic benefits, is a contender in the battle against cancer. Its mode of action rests on disrupting protein-protein interactions, resulting in the arrest of tumor growth. Ovarian and breast cancer, both notorious for their lethality, have been subject to clinical trials with auspicious outcomes